The Trump administration is proposing to halt the public disclosure of hospital infections on the CMS Hospital Compare website; the American Medical Association (AMA) is opposing the proposed merger between CVS Health and Aetna after an analysis of the impact; and health experts are warning about the short- and long-term health impacts of the current zero tolerance immigration policy.
The Hospital Compare website run by CMS may no longer show hospital infections or even safety measures hospitals take under a proposed rule from CMS. According to the USA Today, the Trump administration is proposing to halt the public disclosure of hospital infections and hospitals would no longer have to report safety problems to CMS’ Hospital Compare site. The Leapfrog Group is urging people to protest the plan and recently reported that the number of hospitals with no infections is down since 2015.
The American Medical Association (AMA) is opposing the proposed merger between CVS Health and Aetna based on the indication of anticompetitive effects. An analysis of the merger found that it would increase premiums for Medicare Part D, increase drug spending and out-of-pocket costs, and reduce competition, according to an announcement from the AMA. For its analysis, AMA reached out to academic experts in health economics, health policy, and antitrust law. It will publish a more complete report on its analysis at a later date.
Health experts are warning about short- and long-term health issues resulting from the Trump administration’s recent zero tolerance immigration policy, which has separated thousands of children from their parents at the US border. In addition to mental health conditions, like depression, anxiety, and post-traumatic stress disorder, the stress of the separations can lead to heart disease, stroke, diabetes, and cancer down the line, reported The Hill. The American Psychological Association, American Psychiatric Association, and the American Academy of Pediatrics have all spoken out against the current policy.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More